Literature DB >> 23059646

Glycoprotein 2 antibodies in inflammatory bowel disease: no association with disease phenotype?

Dirk Roggenbuck, René-Louis Humbel, Dirk Reinhold, Dimitrios P Bogdanos, Karsten Conrad, Martin W Laass.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23059646     DOI： 10.1097/MPG.0b013e318275fa77

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  4 in total

1.  Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease.

Authors:  Martin W Laass; Nadja Röber; Ursula Range; Lydia Noß; Dirk Roggenbuck; Karsten Conrad
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

2.  Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype.

Authors:  Mandy Sowa; Rafał Kolenda; Daniel C Baumgart; Johann Pratschke; Maria Papp; Tamas Tornai; Jaroslaw Suchanski; Dimitrios P Bogdanos; Maria G Mytilinaiou; Jutta Hammermann; Martin W Laass; Karsten Conrad; Christoph Schramm; Andre Franke; Dirk Roggenbuck; Peter Schierack
Journal:  Front Immunol       Date:  2018-08-28       Impact factor: 7.561

3.  The Novel Crohn's Disease Marker Anti-GP2 Antibody Is Associated with Ileocolonic Location of Disease.

Authors:  Valentina Somma; Hani Ababneh; Ahmad Ababneh; Simona Gatti; Vittorio Romagnoli; Emanuele Bendia; Karsten Conrad; Dimitrios P Bogdanos; Dirk Roggenbuck; Gino Ciarrocchi
Journal:  Gastroenterol Res Pract       Date:  2013-05-15       Impact factor: 2.260

Review 4.  CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseases.

Authors:  Christos Liaskos; Eirini I Rigopoulou; Timoklia Orfanidou; Dimitrios P Bogdanos; Christos N Papandreou
Journal:  Clin Dev Immunol       Date:  2013-04-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.